tolazoline has been researched along with Child Development Deviations in 2 studies
Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, RS | 1 |
| Stevenson, DK | 1 |
| Malachowski, N | 1 |
| Ariagno, RL | 1 |
| Johnson, JD | 1 |
| Sunshine, P | 1 |
| Andrews, AF | 1 |
| Nixon, CA | 1 |
| Cilley, RE | 1 |
| Roloff, DW | 1 |
| Bartlett, RH | 1 |
2 other studies available for tolazoline and Child Development Deviations
| Article | Year |
|---|---|
Late morbidity among survivors of respiratory failure treated with tolazoline.
Topics: Child, Preschool; Developmental Disabilities; Humans; Infant, Newborn; Respiratory Distress Syndrome | 1980 |
One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation.
Topics: Cerebral Hemorrhage; Developmental Disabilities; Electroencephalography; Extracorporeal Circulation; | 1986 |